Medicus, Vol. 24 No. 2 ASK niske doze, 2015.
Pregledni rad
Gastrointestinal Endoscopy and Acetylsalicylic Acid: What a Family Physician Needs to Know?
Hrvoje Iveković
Nadan Rustemović
Sažetak
Gastrointestinal endoscopy in patients on antiplatelet therapy is characterised by two clinical scenarios. Due to the ulcerogenic potential of acetylsalicylic acid, there is an increased risk of gastrointestinal haemorrhage, especially in the elderly. In that regard, the role of the family physician is to recognise the population at risk and to implement preventive measures. The other clinical situation is the preparation of patients on antiplatelet therapy for invasive gastrointestinal endoscopy interventions. A decision whether or not to discontinue antiplatelet therapy is balanced against the risk of thromboembolic events and the risk of post-procedural bleeding. The family physician should be aware of both these risk factors before the planned procedure. However, in patients with a high risk of thromboembolic events in whom a high-risk procedure is contemplated, this decision is made jointly by cardiologist and endoscopist on an individual basis.
Ključne riječi
gastrointestinal endoscopy; acetylsalicylic acid; gastrointestinal bleeding; post-polypectomy bleeding
Hrčak ID:
148029
URI
Datum izdavanja:
4.11.2015.
Posjeta: 2.302 *